Raymond James & Associates XERIS PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
N/A
-92,900 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
N/A
92,900 New
92,900 $378,000
Q4 2020

Feb 12, 2021
SELL
N/A
-18,515 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
N/A
18,515 New
18,515 $110,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email